| Pediatric glioma-associated KIAA1549:BRAF expression regulates neuroglial cell growth in a cell type-specific and mTOR-dependent manner. Kaul A., Chen Y.H., Emnett R.J., Dahiya S., Gutmann D.H.
Genes Dev. 26:2561-2566(2012) · Mapped (4) |
| Concerted control of gliogenesis by InR/TOR and FGF signalling in the Drosophila post-embryonic brain. Avet-Rochex A., Kaul A.K., Gatt A.P., McNeill H., Bateman J.M.
Development 139:2763-2772(2012) · Mapped (19) |
| Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication. Metz P., Dazert E., Ruggieri A., Mazur J., Kaderali L., Kaul A., Zeuge U., Trippler M., Lohmann V., Binder M. et al.
Hepatology 56:2082-2093(2012) · UniProtKB (1) |
| Regulated temporal-spatial astrocyte precursor cell proliferation involves BRAF signalling in mammalian spinal cord. Tien A.C., Tsai H.H., Molofsky A.V., McMahon M., Foo L.C., Kaul A., Dougherty J.D., Heintz N., Gutmann D.H., Barres B.A. et al.
Development 139:2477-2487(2012) · Mapped (8) |
| Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment. Reiss S., Rebhan I., Backes P., Romero-Brey I., Erfle H., Matula P., Kaderali L., Poenisch M., Blankenburg H., Hiet M.S. et al.
Cell Host Microbe 9:32-45(2011) · Mapped (6) |
| A striking local esophageal cytokine expression profile in eosinophilic esophagitis. Blanchard C., Stucke E.M., Rodriguez-Jimenez B., Burwinkel K., Collins M.H., Ahrens A., Alexander E.S., Butz B.K., Jameson S.C., Kaul A. et al.
J. Allergy Clin. Immunol. 127:208-17, 2011:217.e1-7(2011) · Mapped (2) |
| Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus. Diegelmann J., Beigel F., Zitzmann K., Kaul A., Goke B., Auernhammer C.J., Bartenschlager R., Diepolder H.M., Brand S.
PLoS ONE 5:e15200-e15200(2010) · Mapped (5) |
| Status of bacterial colonization, Toll-like receptor expression and nuclear factor-kappa B activation in normal and diseased human livers. Singh R., Bullard J., Kalra M., Assefa S., Kaul A.K., Vonfeldt K., Strom S.C., Conrad R.S., Sharp H.L., Kaul R.
Clin. Immunol. 138:41-49(2011) · Mapped (5) |
| Polymorphism in glutathione S-transferase P1 is associated with susceptibility to Plasmodium vivax malaria compared to P. falciparum and upregulates the GST level during malarial infection. Sohail M., Kumar R., Kaul A., Arif E., Kumar S., Adak T.
Free Radic. Biol. Med. 49:1746-1754(2010) · Mapped (3) |
| Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis. Blanchard C., Stucke E.M., Burwinkel K., Caldwell J.M., Collins M.H., Ahrens A., Buckmeier B.K., Jameson S.C., Greenberg A., Kaul A. et al.
J. Immunol. 184:4033-4041(2010) · Mapped (17) |
| TLRR (lrrc67) interacts with PP1 and is associated with a cytoskeletal complex in the testis. Wang R., Kaul A., Sperry A.O.
Biol. Cell 102:173-189(2010) · UniProtKB (3) · Mapped (11) |
| Alleles -308A and -1031C in the TNF-alpha gene promoter do not increase the risk but associated with circulating levels of TNF-alpha and clinical features of vivax malaria in Indian patients. Sohail M., Kaul A., Bali P., Raziuddin M., Singh M.P., Singh O.P., Dash A.P., Adak T.
Mol. Immunol. 45:1682-1692(2008) · Mapped (6) |
| Genetic structure of Plasmodium falciparum field isolates in eastern and north-eastern India. Joshi H., Valecha N., Verma A., Kaul A., Mallick P.K., Shalini S., Prajapati S.K., Sharma S.K., Dev V., Biswas S. et al.
Malar. J. 6:60-60(2007) · UniProtKB (35) |
| Activated Ras induces cytoplasmic vacuolation and non-apoptotic death in glioblastoma cells via novel effector pathways. Kaul A., Overmeyer J.H., Maltese W.A.
Cell. Signal. 19:1034-1043(2007) · Mapped (13) |
| The Hlx homeobox transcription factor is required early in enteric nervous system development. Bates M.D., Dunagan D.T., Welch L.C., Kaul A., Harvey R.P.
BMC Dev. Biol. 6:33-33(2006) · Mapped (13) |
| Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Pietschmann T., Kaul A., Koutsoudakis G., Shavinskaya A., Kallis S., Steinmann E., Abid K., Negro F., Dreux M., Cosset F.L. et al.
Proc. Natl. Acad. Sci. U.S.A. 103:7408-7413(2006) · UniProtKB (1) |
| Correlation between a gene polymorphism of tumor necrosis factor-alpha (G/A) and end-stage renal disease: a pilot study from north India. Manchanda P.K., Kumar A., Kaul A., Mittal R.D.
Clin. Chim. Acta 370:152-157(2006) · Mapped (6) |
| Hepatitis C virus RNA replication is resistant to tumour necrosis factor-alpha. Frese M., Barth K., Kaul A., Lohmann V., Schwarzle V., Bartenschlager R.
J. Gen. Virol. 84:1253-1259(2003) · Mapped (6) |
| Myf-5 revisited: loss of early myotome formation does not lead to a rib phenotype in homozygous Myf-5 mutant mice. Kaul A., Koster M., Neuhaus H., Braun T.
Cell 102:17-19(2000) · Mapped (53) |
| A tissue-specific coactivator of steroid receptors, identified in a functional genetic screen. Knutti D., Kaul A., Kralli A.
Mol. Cell. Biol. 20:2411-2422(2000) · UniProtKB (1) |
| Expression of complement regulatory proteins-CD 35, CD 46, CD 55, and CD 59-in benign and malignant endometrial tissue. Murray K.P., Mathure S., Kaul R., Khan S., Carson L.F., Twiggs L.B., Martens M.G., Kaul A.
Gynecol. Oncol. 76:176-182(2000) · Mapped (4) |
